Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (571-580 of 721) with videos related to

Pageof 73
Sort By:
European Radiology|April 29, 2021
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patientsNils Martin Bruckmann, Julian Kirchner, Lale Umutlu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2024
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic CentersAndrea Farolfi, Wesley R Armstrong, Loic Djaileb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PETAlina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Gerhard Held, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG-PET/CT external beam radiation treatment planning in lung cancerSofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2020
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 eraVíctor Rodriguez-Freixinos, Jaume Capdevila, Marianne Pavel, et al.
The Lancet. Oncology|May 29, 2025
Health-related quality of life, pain, and symptomatic skeletal events with [<sup>177</sup>Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trialKarim Fizazi, Michael J Morris, Neal D Shore, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2023
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine TumorsThomas A Hope, Martin Allen-Auerbach, Lisa Bodei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023
Evaluation of [<sup>68</sup>Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital SpaceAleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 16, 2023
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the <sup>68</sup>Ga-FAPI PET Observational TrialLukas Kessler, Nader Hirmas, Kim M Pabst, et al.
Pageof 73

Showing results (571-580 of 721) with videos related to

Sort By:
Pageof 73
European Radiology|April 29, 2021
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patientsNils Martin Bruckmann, Julian Kirchner, Lale Umutlu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2024
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic CentersAndrea Farolfi, Wesley R Armstrong, Loic Djaileb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PETAlina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Gerhard Held, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[<sup>18</sup>F]FDG-PET/CT external beam radiation treatment planning in lung cancerSofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2020
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 eraVíctor Rodriguez-Freixinos, Jaume Capdevila, Marianne Pavel, et al.
The Lancet. Oncology|May 29, 2025
Health-related quality of life, pain, and symptomatic skeletal events with [<sup>177</sup>Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trialKarim Fizazi, Michael J Morris, Neal D Shore, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2023
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine TumorsThomas A Hope, Martin Allen-Auerbach, Lisa Bodei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023
Evaluation of [<sup>68</sup>Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital SpaceAleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 16, 2023
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the <sup>68</sup>Ga-FAPI PET Observational TrialLukas Kessler, Nader Hirmas, Kim M Pabst, et al.
Pageof 73